	Notch receptors in breast cancer: context-dependent roles and therapeutic targeting. Cell Commun Signal Wang M, Mi Y, Ye Q. PMID: 42469819 [PubMed - as supplied by publisher]
	Risk-based breast cancer screening. Br J Cancer Jørgensen KJ, Brodersen JB. PMID: 42469440 [PubMed - as supplied by publisher]
	A Machine-Learning Model Using Pre-treatment Multimodal Data to Predict Sentinel Lymph Node Status After Neoadjuvant Chemotherapy in Operable Early-stage Breast Cancer. Acad Radiol Jin M, Yang A, Liu Y, Peng Y, Tian J, Ou W, Jiang J, Duan Z, Shu J. PMID: 42469044 [PubMed - as supplied by publisher]
	Non-Pharmacological Interventions for Postoperative Pain in Breast Cancer Patients: A Network Meta-analysis. Pain Manag Nurs Wang Y, Song J, Zhang H, Maniago J, Li Y, Xia Z, Zhang D, Sun W, Jiang H. PMID: 42469038 [PubMed - as supplied by publisher]
	Current Status and Prospects of Chemotherapy-Free Strategies in Ovarian Cancer. Crit Rev Oncol Hematol Jiang C, Li Z. PMID: 42468792 [PubMed - as supplied by publisher]
	A practical approach to breast cancer risk assessment and management of women at elevated risk. Maturitas Etkin-Kramer E, Pederson HJ, Larkin LC. PMID: 42468287 [PubMed - as supplied by publisher]
	Understanding cachexia and muscle dysfunction in the context of metastatic breast cancer. Cancer Metastasis Rev Saunders AAE, Anderson RL, Gregorevic P. PMID: 42469541 [PubMed - indexed for MEDLINE]
	Breast cancer detection and classification via a robust deep learning approach. Sci Rep Makram M, Aziz AS, Saeid MM, Mohamed MT. PMID: 42469341 [PubMed - indexed for MEDLINE]
	Foundation Model-empowered Multimodal Prediction of Platinum Resistance in High-grade Serous Ovarian Cancer: A Multicenter Retrospective Study. Acad Radiol Bi Q, Qu L, Liu Y, Wang Q, Meng Q, Yang J, Wu Y, Ai C, Miao K, Wu L. PMID: 42469040 [PubMed - as supplied by publisher]
	The RAC1 tripartite hub: coupling metabolic plasticity and immune evasion to dictate breast cancer cell fate. Biochem Pharmacol Lin HY, Chen YH, Chu PY. PMID: 42468635 [PubMed - as supplied by publisher]
	Dosimetry and toxicity outcomes of knowledge-based volumetric modulated arc therapy for breast cancer: A retrospective cohort analysis. Radiother Oncol Chan J, Knight A, Baker L, Metz G, Morgia M, Lamoury G, Bromley R, Griffiths B, Carroll S. PMID: 42468606 [PubMed - as supplied by publisher]
	Axillary Management After Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer. Clin Breast Cancer Gu Z, Zhang Y, Ye Y, Qian W. PMID: 42468453 [PubMed - as supplied by publisher]
	Striving for completeness: Women's long-term experiences of living with a reconstructed breast after breast cancer - an interview study. Eur J Oncol Nurs Ahlstedt Karlsson S, Andrade C, Myrin-Westesson L, Larsson C, Uusimaki A, Svensson K, Paganini A. PMID: 42468414 [PubMed - as supplied by publisher]
	Ovarian Cancer Diagnosis and Chemoresistance Prediction Model Based on cfRNA Molecular Signature. Adv Sci (Weinh) Guo Q, Zhang Y, Jin Y, Deng S, Chen Y, Feng Z, Wen H, Wang L, Li Y, Ou F, Shen Y, Li H, Zhou T, Ju X, Wu X. PMID: 42467997 [PubMed - as supplied by publisher]
	Metabolic signatures of triple-negative breast cancer. Mol Biol Rep Pusalkar G, Madamakki R, Chakraborty P, Parodi A, Lopus M. PMID: 42467335 [PubMed - indexed for MEDLINE]
	Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer. Clin Cancer Res Dieci MV, Gasparini E, Nicolè L, Schmid P, Zambelli A, Favaretto A, Piacentini F, Bianchi GV, Mion M, Ferro A, Arpino G, Emiliani A, Cinieri S, Zamagni C, Gennari A, Spazzapan S, Sartori D, Zustovich F, Tamberi S, Del Mastro L, De Laurentiis M, Musolino A, Cagossi K, Generali D, Giarratano T, Giovanardi F, De Salvo GL, Conte P, Guarneri V. PMID: 42467210 [PubMed - as supplied by publisher]
	Patterns of Care and Follow-up of Patients with an Ipsilateral Breast Tumor Event After Breast-Conserving Surgery: A Multicenter Retrospective Cohort Study in the Netherlands. Ann Surg Oncol Wurfbain LF, Tiels LM, van der Sangen MJC, Walstra CJEF, van Maaren MC, Vriens BEPJ, van Oordt CWMH, Bloemen JG, Voogd AC, Nieuwenhuijzen GAP, van den Bongard DHJG, Schipper RJ, Dutch Snapshot Research Group. PMID: 42467154 [PubMed - as supplied by publisher]
	Impact of Neoadjuvant Immunochemotherapy on Surgical Outcomes in Management of Early Triple-Negative Breast Cancer. Breast J Khadrouche T, Morisseau M, Selmes G, Vaysse C, Franchet C, Massabeau C, Ung M, Maio E, Lacaze JL, Jouve E. PMID: 42467061 [PubMed - indexed for MEDLINE]
	Claudin-6 as a potential target in the treatment of ovarian cancer: a review of emerging drugs. Expert Opin Emerg Drugs Ottum S, Sethi N, Demirkiran C, De Tommasi O, Santin AD. PMID: 42466859 [PubMed - as supplied by publisher]
	Incidence, Trends, and Racial/Ethnic Disparities in Female Breast Cancer in the United States, 2000-2023: A SEER Based Study. Cancer Control Mzizi NO, Ndabezitha SS, Atta JA, Al Zoubi MA, Akkala S. PMID: 42466659 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 332378

Page 1 of 16619



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy